+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics in Belarus

  • ID: 4417269
  • Report
  • Region: Belarus
  • 17 pages
  • Euromonitor International
1 of 2
Analgesics recorded stable single-digit retail value growth in 2018, largely due to inflation, as retail volume sales continued to decline. Low disposable incomes encouraged Belarusians to economise and keep a careful eye on their outgoings by switching to less expensive domestic generics, which also limited retail value growth.

The Analgesics in Belarus report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 2
ANALGESICS IN BELARUS
January 2019

List of Contents and Tables
Headlines
Prospects
Topical Analgesics/anaesthetic and Ibuprofen Lead Value Growth
Pharmacists' Advice and the Conservatism of Consumers Key Aspects in Analgesics
the Economising Trend Boosts Sales of Inexpensive Domestic Generics
Competitive Landscape
Domestic Companies Continue To Lead With A Strong Presence in All Analgesics Categories
Competition Continues To Be Based on Price and Product Availability
Saturation Remains Due To the Large Number of Domestic Products
Category Data
Table 1 Sales of Analgesics by Category: Value 2013-2018
Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Benefits From the Trends Towards Economising and Self-care and the Active Development of Pharmacies
Consumer Trends and State Regulation Lead To Stable Value Growth
Price-based Competition Persists
Government Limits the Development of Sales Channels for OTC and Vitamin and Dietary Supplements
Growth Expected Due To Consumer Preferences, the Economising Trend, the Spread of Maladies and State Control
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Distribution of Consumer Health by Format: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format and Category: % Value 2018
Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Sources
Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Order Online - visit: https://www.researchandmarkets.com/reports/4417269
Adroll
adroll